Preview Mode Links will not work in preview mode

Apr 13, 2021

Featuring slide presentations and related discussion from Drs Harold J Burstein and Lisa Carey, including the following topics:

  • ER-Positive Breast Cancer, PARP Inhibitors and Sacituzumab Govitecan — Harold J Burstein, MD, PhD (0:00)
  • HER2-Positive and Triple-Negative Breast Cancer — Lisa A Carey, MD (43:52)


Apr 13, 2021

Featuring perspectives from Drs Harold J Burstein and Lisa Carey on the following topics:

  • ER-Positive, HER2-Negative Breast Cancer
    • Introduction (0:00)
    • CDK4/6 inhibitors for ER-positive breast cancer (3:53)
    • Role of PI3K inhibitors for ER-positive metastatic breast cancer (mBC) (13:31)
    • Use of genomic assays for...


Apr 6, 2021

Featuring a roundtable discussion with Drs Virginia F Borges, Sara Hurvitz and Ian E Krop, including the following topics:

  • Introduction
    • Impact of COVID-19 vaccinations on screening for breast cancer (0:00)
  • Management of HER2-positive early breast cancer
    • Case: A woman in her early 40s with...


Apr 3, 2021

Proceedings from the first of 2 sessions on HER2-positive breast cancer. Featuring perspectives from Dr Erika Hamilton, including the following topics:

  • Introduction and review of SABCS 2020 Educational Session on HER2-targeted therapy (0:00)
  • Case: A 42-year-old premenopausal woman with ER-positive, HER2-positive,...


Apr 2, 2021

Proceedings from the first of 2 sessions on triple-negative breast cancer. Featuring perspectives from Dr P Kelly Marcom, including the following topics:

  • Introduction and Review of San Antonio Breast Cancer Symposium 2020 Educational Session on Triple-Negative Breast Cancer (TNBC) (0:00)
  • Optimal Integration of Immune...